These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 7801608)
21. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Sharp CP; Lail A; Donfield S; Gomperts ED; Simmonds P Transfusion; 2012 Jul; 52(7):1482-9. PubMed ID: 22043925 [TBL] [Abstract][Full Text] [Related]
22. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. Mannucci PM; Schimpf K; Brettler DB; Ciavarella N; Colombo M; Haschke F; Lechner K; Lusher J; Weissbach G Ann Intern Med; 1990 Jul; 113(1):27-32. PubMed ID: 2112352 [TBL] [Abstract][Full Text] [Related]
23. Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. The Study Group of the Fondazione dell'Emofilia. Mannucci PM; Zanetti AR; Colombo M; Chistolini A; De Biasi R; Musso R; Tamponi G Thromb Haemost; 1990 Oct; 64(2):232-4. PubMed ID: 2176748 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus antibodies in high-risk Saudi groups. Bahakim H; Bakir TM; Arif M; Ramia S Vox Sang; 1991; 60(3):162-4. PubMed ID: 1907415 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection. Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772 [TBL] [Abstract][Full Text] [Related]
26. Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. G.I.C.C. Gruppo Italiano Coagulopatie Congenite. Schinaia N; Ghirardini AM; Mazzucconi MG; Tagariello G; Morfini M; Chiarotti F Thromb Haemost; 1994 Jul; 72(1):33-8. PubMed ID: 7974372 [TBL] [Abstract][Full Text] [Related]
27. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Ghany MG; Leissinger C; Lagier R; Sanchez-Pescador R; Lok AS Dig Dis Sci; 1996 Jun; 41(6):1265-72. PubMed ID: 8654162 [TBL] [Abstract][Full Text] [Related]
28. Prevalence and persistence of a novel DNA TT virus (TTV) infection in Japanese haemophiliacs. Takayama S; Miura T; Matsuo S; Taki M; Sugii S Br J Haematol; 1999 Mar; 104(3):626-9. PubMed ID: 10086806 [TBL] [Abstract][Full Text] [Related]
29. Infection with hepatitis G virus among recipients of plasma products. Jarvis LM; Davidson F; Hanley JP; Yap PL; Ludlam CA; Simmonds P Lancet; 1996 Nov; 348(9038):1352-5. PubMed ID: 8918279 [TBL] [Abstract][Full Text] [Related]
30. The Natural History of Hepatitis C Virus Infection in Hemophiliacs. Franchini M; Tagliaferri A; Rossetti G; Capra F; De Maria E; Pattacini C; Gandini G Hematology; 2001; 6(2):135-42. PubMed ID: 27419880 [TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of hepatitis C, hepatitis B and HIV viruses in hemophiliacs born 1985-2010 in west Azarbaijan of Iran. Valizadeh N; Nateghi S; Noroozi M; Hejazi S; Aghanezhad F; Ali AA Asian J Transfus Sci; 2013 Jan; 7(1):55-8. PubMed ID: 23559767 [TBL] [Abstract][Full Text] [Related]
32. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. Santagostino E; Mannucci PM; Gringeri A; Azzi A; Morfini M; Musso R; Santoro R; Schiavoni M Transfusion; 1997 May; 37(5):517-22. PubMed ID: 9149778 [TBL] [Abstract][Full Text] [Related]
33. [Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders]. Zenz W; Hofmann H; Muntean W Wien Klin Wochenschr; 1991; 103(3):69-72. PubMed ID: 1851352 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools. Rollag H; Evesen SA; Fröland SS; Glomstein A Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):612-4. PubMed ID: 2170135 [TBL] [Abstract][Full Text] [Related]
35. HTLV III antibodies and immunological alterations in hemophilia patients. Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759 [TBL] [Abstract][Full Text] [Related]
36. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Azzi A; Ciappi S; Zakvrzewska K; Morfini M; Mariani G; Mannucci PM Am J Hematol; 1992 Mar; 39(3):228-30. PubMed ID: 1312304 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis C antibody and chronic liver disease in haemophilia. Makris M; Preston FE; Triger DR; Underwood JC; Choo QL; Kuo G; Houghton M Lancet; 1990 May; 335(8698):1117-9. PubMed ID: 1971863 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of hepatitis C virus infection in coagulation disorders in Japan. Taki M; Tatsunami S; Shirahata A; Fukutake K; Mimaya J; Yamada K Int J Hematol; 2003 Jun; 77(5):528-9. PubMed ID: 12841395 [No Abstract] [Full Text] [Related]
39. Hepatitis C contributes to liver disease in children and adolescents with hemophilia. Wagner N; Rotthauwe HW Klin Padiatr; 1994; 206(1):40-4. PubMed ID: 7512169 [TBL] [Abstract][Full Text] [Related]
40. Coinfection with hepatitis viruses and human immunodeficiency virus in multiply transfused patients. Brenner B; Back D; Ben-Porath E; Hazani A; Martinowitz U; Tatarsky I Isr J Med Sci; 1994 Dec; 30(12):886-90. PubMed ID: 8002269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]